Table 2.
Antibiotic Preferences for Patients with CAP
| All Physicians | ID Specialists | Generalists | ||||
|---|---|---|---|---|---|---|
| Drug | Mean Rank* | Relative Preference† | Mean Rank* | Relative Preference† | Mean Rank* | Relative Preference† |
| Azithromycin | 3.1 | 3.4‡ | 2.9 | 5.1‡ | 3.2 | 2.1‡ |
| Levofloxacin | 4.1 | 1.6‡ | 3.5 | 3.1‡ | 4.8 | 0.8 |
| Amoxicillin/clavulanate | 4.6 | 1.6‡ | 4.8 | 1.9‡ | 4.3 | 1.2 |
| Cefuroxime axetil | 4.8 | 1.4‡ | 4.5 | 2.2‡ | 5.2 | 0.8 |
| Erythromycin | 5.3 | Reference | 5.9 | Reference | 4.6 | Reference |
| Doxycycline | 6.0 | 0.7‡ | 5.7 | 1.1 | 6.4 | 0.5‡ |
| Amoxicillin | 6.2 | 0.6‡ | 6.5 | 0.8 | 5.9 | 0.5‡ |
| Cefpodoxime proxetil | 6.7 | 0.6‡ | 6.4 | 0.9 | 7.0 | 0.4‡ |
| Trimethoprim-sulfamethoxazole | 6.8 | 0.6‡ | 6.7 | 0.8 | 6.8 | 0.4‡ |
| Ciprofloxacin | 7.4 | 0.4‡ | 8.0 | 0.4‡ | 6.7 | 0.4‡ |
*
Physicians ranked their choices of antibiotic from 1 = most preferred to 10 = least preferred.
†
Relative preferences for each antibiotic were generated based on the exploded logit model that calculates the relative risk of ranking each antibiotic lower (i.e., more preferred) compared to the reference choice, erythromycin.
‡
P < .0001 compared to reference category.
CAP, community-acquired pneumonia; ID, infectious diseases.